Beckwith-Wiedemann and Russell-Silver Syndromes: from new molecular insights to the comprehension of imprinting regulation

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 21, Issue 1, 2014, Pages 30-38

  Azzi, Salah ^a,b,c   Habib, Walid Abi ^a,b,c   Netchine, Irene ^a,b,c  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c INSERM   (France)

Author keywords

11p15 related syndromes; Beckwith Wiedemann syndrome; imprinting defects related metabolic disorders; multilocus imprinting disorders; Russell Silver Syndrome

Indexed keywords

CIS ACTING ELEMENT; TRANS ACTING FACTOR;

BECKWITH WIEDEMANN SYNDROME; CHROMOSOME 11P; EPIGENETICS; FETUS GROWTH; GENE CONTROL; GENETIC COUNSELING; HUMAN; METABOLIC DISORDER; MOLECULAR IMPRINTING; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SILVER RUSSELL SYNDROME;

BECKWITH-WIEDEMANN SYNDROME; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC COUNSELING; GENETIC TESTING; GENOMIC IMPRINTING; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR II; MALE; POTASSIUM CHANNELS, VOLTAGE-GATED; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; RISK ASSESSMENT; SILVER-RUSSELL SYNDROME;

EID: 84892371264     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000037     Document Type: Review

References (76)

1. Gicquel C, El-Osta A, Le Bouc Y. Epigenetic regulation and fetal programming. Best Pract Res 2008; 22: 1-16
2. Abramowitz LK, Bartolomei MS. Genomic imprinting: Recognition and marking of imprinted loci. Curr Opin Genet Dev 2012; 22: 72-78
3. Hajkova P, Erhardt S, Lane N, et al. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 2002; 117: 15-23
4. Oswald J, Engemann S, Lane N, et al. Active demethylation of the paternal genome in the mouse zygote. Curr Biol 2000; 10: 475-478
5. Santos F, Hendrich B, Reik W, Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol 2002; 241: 172-182
6. Kelsey G, Feil R. New insights into establishment and maintenance of DNA methylation imprints in mammals. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20110336
7. Seki Y, Hayashi K, Itoh K, et al. Extensive and orderly reprogramming of genome-wide chromatin modifications associated with specification and early development of germ cells in mice. Dev Biol 2005; 278: 440-458
8. Azzi S, Brioude F, Le Bouc Y, Netchine I. Human imprinting anomalies in Fetal and Childhood Growth Disorders: Clinical implications and molecular mechanisms. Curr Pharm Des 2013. [Epub ahead of print
9. Tomizawa S, Sasaki H. Genomic imprinting and its relevance to congenital disease, infertility, molar pregnancy and induced pluripotent stem cell. J Hum Genet 2012; 57: 84-91
10. Azzi S, Rossignol S, Le Bouc Y, Netchine I. Lessons from imprinted multilocus loss of methylation in human syndromes: A step toward understanding the mechanisms underlying these complex diseases. Epigenetics 2010; 5: 373-377
11. Wiedemann HR. The EMG-syndrome: Exomphalos, macroglossia, gigantism and disturbed carbohydrate metabolism. Z Kinderheilkd 1969; 106: 171-185
12. Pettenati MJ, Haines JL, Higgins RR, et al. Wiedemann-Beckwith syndrome: Presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet 1986; 74: 143-154
13. Elliott M, Bayly R, Cole T, et al. Clinical features and natural history of Beckwith-Wiedemann syndrome: Presentation of 74 new cases. Clin Genet 1994; 46: 168-174
14. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998; 132 (3 Pt 1): 398-400
15. Weksberg R, Nishikawa J, Caluseriu O, et al. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 2001; 10:2989-3000.
16. Engstrom W, Lindham S, Schofield P. Wiedemann-Beckwith syndrome. Eur J Pediatr 1988; 147: 450-457
17. Bliek J, Gicquel C, Maas S, et al. Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 2004; 145: 796-799
18. Cooper WN, Luharia A, Evans GA, et al. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2005; 13: 1025-1032
19. Eggermann T, Algar E, Lapunzina P, et al. Clinical utility gene card for: Beckwith-Wiedemann syndrome. Eur J Hum Genet 2013. [Epub ahead of print
20. Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-Analysis. Am J Med Genet A 2005; 136: 95-104
21. Abu-Amero S, Wakeling EL, Preece M, et al. Epigenetic signatures of Silver-Russell syndrome. J Med Genet 2010; 47: 150-154
22. Netchine I, Rossignol S, Dufourg MN, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: Clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab 2007; 92: 3148-3154
23. Price SM, Stanhope R, Garrett C, et al. The spectrum of Silver-Russell syndrome: A clinical and molecular genetic study and new diagnostic criteria. J Med Genet 1999; 36: 837-842
24. Wakeling EL, Amero SA, Alders M, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet 2010; 47: 760-768
25. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995; 311: 171-174
26. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev 2005; 85: 571-633
27. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005; 37: 1003-1007
28. Gaston V, Le Bouc Y, Soupre V, et al. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur J Hum Genet 2001; 9: 409-418
29. Cooper WN, Curley R, Macdonald F, Maher ER. Mitotic recombination and uniparental disomy in Beckwith-Wiedemann syndrome. Genomics 2007; 89: 613-617
30. Romanelli V, Meneses HN, Fernandez L, et al. Beckwith-Wiedemann syndrome and uniparental disomy 11p: Fine mapping of the recombination breakpoints and evaluation of several techniques. Eur J Hum Genet 2011; 19: 416-421
31. Bullman H, Lever M, Robinson DO, et al. Mosaic maternal uniparental disomy of chromosome 11 in a patient with Silver-Russell syndrome. J Med Genet 2008; 45: 396-399
32. Arboleda VA, Lee H, Parnaik R, et al. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nature genetics 2012; 44: 788-792
33. Brioude F, Oliver-Petit I, Blaise A, et al. CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome. J Med Genet 2013; 50: 823-830
34. Bliek J, Snijder S, Maas SM, et al. Phenotypic discordance upon paternal or maternal transmission of duplications of the 11p15 imprinted regions. Eur J Med Genet 2009; 52: 404-408
35. Demars J, Rossignol S, Netchine I, et al. New insights into the pathogenesis of beckwith-wiedemann and silver-russell syndromes: Contribution of small copy number variations to 11p15 imprinting defects. Hum Mutat 2011; 32: 1171-1182
36. Soejima H, Higashimoto K. Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders. J Hum Genet 2013; 58: 402-409
37. Algar EM, St Heaps L, Darmanian A, et al. Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin-like growth factor II in overgrowth and Wilms' tumorigenesis. Cancer Res 2007; 67: 2360-2365
38. Russo S, Finelli P, Recalcati MP, et al. Molecular and genomic characterisation of cryptic chromosomal alterations leading to paternal duplication of the 11p15.5 Beckwith-Wiedemann region. J Med Genet 2006; 43: E39
39. Bonaldi A, Mazzeu JF, Costa SS, et al. Microduplication of the ICR2 domain at chromosome 11p15 and familial Silver-Russell syndrome. Am J Med Genet A 2011; 155A: 2479-2483
40. Schonherr N, Meyer E, Roos A, et al. The centromeric 11p15 imprinting centre is also involved in Silver-Russell syndrome. J Med Genet 2007; 44: 59-63
41. Chiesa N, De Crescenzo A, Mishra K, et al. The KCNQ1OT1 imprinting control region and noncoding RNA: New properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases. Hum Mol Genet 2012; 21: 10-25
42. Demars J, Shmela ME, Rossignol S, et al. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCTbinding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet 2010; 19: 803-814
43. Beygo J, Citro V, Sparago A, et al. The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites. Hum Mol Genet 2013; 22: 544-557
44. Prawitt D, Enklaar T, Gartner-Rupprecht B, et al. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci U S A 2005; 102: 4085-4090
45. Sparago A, Cerrato F, Vernucci M, et al. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome. Nature genetics 2004; 36: 958-960
46. Sparago A, Russo S, Cerrato F, et al. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour. Hum Mol Genet 2007; 16: 254-264
47. Sakaguchi R, Okamura E, Matsuzaki H, et al. Sox-Oct motifs contribute to maintenance of the unmethylated H19 ICR in YAC transgenic mice. Hum Mol Genet 2013; 22: 4627-4637
48. Gronskov K, Poole RL, Hahnemann JM, et al. Deletions and rearrangements of the H19/IGF2 enhancer region in patients with Silver-Russell syndrome and growth retardation. J Med Genet 2011; 48: 308-311
49. Poole RL, Leith DJ, Docherty LE, et al. Beckwith-Wiedemann syndrome caused by maternally inherited mutation of an OCT-binding motif in the IGF2/ H19-imprinting control region, ICR1. Eur J Hum Genet 2011; 20: 240-243
50. Weth O, Renkawitz R. CTCF function is modulated by neighboring DNA binding factors. Biochem Cell Biol 2011; 89: 459-468
51. Hori N, Nakano H, Takeuchi T, et al. A dyad oct-binding sequence functions as a maintenance sequence for the unmethylated state within the H19/Igf2-imprinted control region. J Biol Chem 2002; 277: 27960-27967
52. Hori N, Yamane M, Kouno K, Sato K. Induction of DNA demethylation depending on two sets of Sox2 and adjacent Oct3/4 binding sites (Sox-Oct motifs) within the mouse H19/insulin-like growth factor 2 (Igf2) imprinted control region. J Biol Chem 2012; 287: 44006-44016
53. Begemann M, Spengler S, Gogiel M, et al. Clinical significance of copy number variations in the 11p15.5 imprinting control regions: New cases and review of the literature. J Med Genet 2012; 49: 547-553
54. Kannenberg K, Urban C, Binder G. Increased incidence of aberrant DNA methylation within diverse imprinted gene loci outside of IGF2/H19 in Silver-Russell syndrome. Clin Genet 2012; 81: 366-377
55. Maupetit-Mehouas S, Azzi S, Steunou V, et al. Simultaneous hyper-And hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1b. Human mutation 2013; 34: 1172-1180
56. Court F, Martin-Trujillo A, Romanelli V, et al. Genome-wide allelic methylation analysis reveals disease-specific susceptibility to multiple methylation defects in imprinting syndromes. Hum Mutat 2013; 34: 595-602
57. Azzi S, Rossignol S, Steunou V, et al. Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Hum Mol Genet 2009; 18: 4724-4733
58. Bliek J, Verde G, Callaway J, et al. Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 andGNAS loci in Beckwith-Wiedemann syndrome. Eur J Hum Genet 2009; 17: 611-619
59. Lim D, Bowdin SC, Tee L, et al. Clinical and molecular genetic features of Beckwith-Wiedemann syndrome associated with assisted reproductive technologies. Hum Reprod 2009; 24: 741-747
60. Rossignol S, Steunou V, Chalas C, et al. The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region. J Med Genet 2006; 43: 902-907
61. Meyer E, Lim D, Pasha S, et al. Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome). PLoS Genet 2009; 5: E1000423
62. Poole RL, Docherty LE, Al Sayegh A, et al. Targeted methylation testing of a patient cohort broadens the epigenetic and clinical description of imprinting disorders. Am J Med Genet 2013; 161: 2174-2182
63. Turner CL, Mackay DM, Callaway JL, et al. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci. Eur J Hum Genet 2010; 18: 648-655
64. Mackay DJ, Callaway JL, Marks SM, et al. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet 2008; 40: 949-951
65. Mackay DJ, Boonen SE, Clayton-Smith J, et al. A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet 2006; 120: 262-269
66. Perez-Nanclares G, Romanelli V, Mayo S, et al. Detection of hypomethylation syndrome among patients with epigenetic alterations at the GNAS locus. J Clin Endocrinol Metabol 2012; 97: E1060-E1067
67. Begemann M, Spengler S, Kanber D, et al. Silver-Russell patients showing a broad range of ICR1 and ICR2 hypomethylation in different tissues. Clin Genet 2011; 80: 83-88
68. Dyck RF, Klomp H, Tan L. From thrifty genotype' to 'hefty fetal phenotype': The relationship between high birth weight and diabetes in Saskatchewan Registered Indians. Can J Public Health 2001; 92: 340-344
69. Harder T, Rodekamp E, Schellong K, et al. Birth weight and subsequent risk of type 2 diabetes: A meta-Analysis. Am J Epidemiol 2007; 165: 849-857
70. Gluckman PD, Hanson MA, Beedle AS. Early life events and their consequences for later disease: A life history and evolutionary perspective. Am J Hum Biol 2007; 19: 1-19
71. Fowden AL, Giussani DA, Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 2005; 81: 723-734
72. Temple IK, Shield JP. Transient neonatal diabetes, a disorder of imprinting. J Med Genet 2002; 39: 872-875
73. Hoffmann A, Spengler D. Transient neonatal diabetes mellitus gene Zac1 impairs insulin secretion in mice through Rasgrf1. Mol Cell Biol 2012; 32: 2549-2560
74. Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol 2013; 2013: 14
75. Hoffmann K, Heller R. Uniparental disomies 7 and 14. Best Pract Res 2011; 25: 77-100
76. Royo H, Cavaille J. Noncoding RNAs in imprinted gene clusters. Biol Cell 2008; 100: 149-166